Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a Eu...

Por Castellano, D., del Muro, X. Garcia, Pérez-Gracia, J. L., González-Larriba, J. L., Abrio, M. V., Ruiz, M. A., Pardo, A., Guzmán, C., Cerezo, S. Díaz, Grande, E.
Publicado em 2009

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

Por Carles, J, Font, A, Mellado, B, Domenech, M, Gallardo, E, González-Larriba, J L, Catalan, G, Alfaro, J, Gonzalez del Alba, A, Nogué, M, Lianes, P, Tello, J M
Publicado em 2007